Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 30.01%5.05B | 31.28%2.59B | 34.61%3.88B | 40.97%1.97B | 57.78%2.89B | --1.4B | 15.96%1.83B | --1.58B |
| Operating income | 30.01%5.05B | 31.28%2.59B | 34.61%3.88B | 40.97%1.97B | 57.78%2.89B | 1.4B | 15.96%1.83B | 1.58B |
| Cost of sales | -31.23%-796.77M | -37.36%-409.3M | -38.71%-607.18M | -37.74%-297.97M | -47.96%-437.72M | ---216.33M | -13.20%-295.83M | ---261.34M |
| Operating expenses | -31.23%-796.77M | -37.36%-409.3M | -38.71%-607.18M | -37.74%-297.97M | -47.96%-437.72M | -216.33M | -13.20%-295.83M | -261.34M |
| Gross profit | 29.78%4.25B | 30.20%2.18B | 33.87%3.28B | 41.56%1.67B | 59.67%2.45B | 1.18B | 16.51%1.53B | 1.32B |
| Selling expenses | -28.06%-2.44B | -24.77%-1.17B | -34.81%-1.9B | -42.48%-937.21M | -46.75%-1.41B | ---657.79M | -26.07%-962.44M | ---763.43M |
| Administrative expenses | -0.48%-269.05M | -2.30%-136.38M | -39.40%-267.77M | -44.54%-133.31M | -44.39%-192.09M | ---92.23M | -7.00%-133.04M | ---124.34M |
| Impairment and provision | -108.72%-299K | -242.69%-1.07M | 243.49%3.43M | 85.68%752K | 214.32%998K | --405K | 71.56%-873K | ---3.07M |
| -Other impairment is provision | -108.72%-299K | -242.69%-1.07M | 243.49%3.43M | 85.68%752K | 214.32%998K | --405K | 71.56%-873K | ---3.07M |
| Special items of operating profit | -23.66%51.84M | -58.99%22.9M | 48.23%67.91M | 60.56%55.85M | 38.06%45.81M | --34.78M | 54.15%33.18M | --21.53M |
| Operating profit | 35.75%1.6B | 35.69%895.03M | 32.16%1.18B | 41.14%659.64M | 89.45%890.6M | 467.37M | 5.24%470.1M | 446.69M |
| Financing cost | 56.10%-2.32M | 60.02%-1.02M | -160.16%-5.29M | -126.24%-2.56M | 34.74%-2.03M | ---1.13M | -11.05%-3.12M | ---2.81M |
| Share of profits of associates | 131.53%11.62M | 758.50%4.59M | 814.08%5.02M | --535K | ---703K | ---- | ---- | ---- |
| Earning before tax | 36.58%1.61B | 36.65%898.6M | 32.54%1.18B | 41.05%657.61M | 90.13%887.86M | 466.24M | 5.20%466.99M | 443.89M |
| Tax | -35.98%-401.71M | -38.24%-228.18M | -31.65%-295.42M | -41.16%-165.06M | -95.31%-224.39M | ---116.93M | -1.73%-114.89M | ---112.94M |
| After-tax profit from continuing operations | 36.78%1.21B | 36.11%670.42M | 32.84%881.33M | 41.01%492.55M | 88.43%663.47M | 349.31M | 6.39%352.1M | 330.94M |
| Earning after tax | 36.78%1.21B | 36.11%670.42M | 32.84%881.33M | 41.01%492.55M | 88.43%663.47M | 349.31M | 6.39%352.1M | 330.94M |
| Minority profit | 87.47%1.35M | 38.56%654K | -53.44%718K | 30.75%472K | 11,761.54%1.54M | --361K | 117.81%13K | ---73K |
| Profit attributable to shareholders | 36.73%1.2B | 36.11%669.77M | 33.04%880.61M | 41.02%492.07M | 88.00%661.93M | 348.94M | 6.36%352.08M | 331.02M |
| Basic earnings per share | 12.84%2.46 | -44.31%1.37 | -34.14%2.18 | 41.38%2.46 | 88.07%3.31 | 1.74 | 6.02%1.76 | 1.66 |
| Diluted earnings per share | 12.84%2.46 | -44.31%1.37 | -34.14%2.18 | 41.38%2.46 | 88.07%3.31 | 1.74 | 6.02%1.76 | 1.66 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.